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Background
Virus-specific CD4+ T cells with interleukin-2 (IL-2)-
secreting and/or proliferative capacity are detected readily
in HIV-1-infected long-term nonprogressors and rarely in
persons with untreated progressive infection. The contri-
bution of these cells to viremia control is uncertain but
this question might be addressed in clinical therapeutic
vaccination studies. However, the quality of T helper
responses induced by currently available HIV-1 vaccine
candidates has not been explored in depth.
Methods
We determined the effect of vaccination with modified
vaccinia virus Ankara expressing HIV-1 gag p24/p17
(MVA.HIVA) on HIV-1 specific CD4+ T cell responses in
16 chronically infected HAART-treated subjects using
CD8-depleted IFN-g Elispot assays, intracellular cytokine
staining assays for IL-2 and IFN-g and a CFSE-based pro-
liferation assay.
Results
Gag-specific CD4+ T cell responses were significantly
increased in magnitude and breadth after vaccination and
targeted both known and new epitopes, several of which
were also recognized by healthy HIV-uninfected volun-
teers immunized with the same vaccines. The frequencies
of CD4+ T cells expressing IL-2 or IFN-g, alone or simulta-
neously were also augmented.
Conclusion
These findings indicate that functional virus-specific T
helper cells can be boosted by vaccination in chronic HIV-
1 infection. Further evaluation of their role in controlling
viremia is warranted.
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